Ipsen : presents its half year 2020 results and reinstates guidance for full year 2020
Paris , 30 July 2020 - Ipsen , a global specialty-driven biopharmaceutical group, today announced financial results for the first half of 2020. Resilient H1 financial... | June 19, 2023